
### [NCIT:C3692](http://purl.obolibrary.org/obo/NCIT_C3692)
**Label:** Undifferentiated Carcinoma

**Subclasses:** [NCIT:C35718](http://purl.obolibrary.org/obo/NCIT_C35718) (Thymic Undifferentiated Carcinoma), [NCIT:C96792](http://purl.obolibrary.org/obo/NCIT_C96792) (Undifferentiated Liver Carcinoma), [NCIT:C5946](http://purl.obolibrary.org/obo/NCIT_C5946) (Parotid Gland Undifferentiated Carcinoma), [NCIT:C6159](http://purl.obolibrary.org/obo/NCIT_C6159) (Undifferentiated Ureter Carcinoma), [NCIT:C4452](http://purl.obolibrary.org/obo/NCIT_C4452) (Lung Giant Cell Carcinoma), [NCIT:C27419](http://purl.obolibrary.org/obo/NCIT_C27419) (Ampulla of Vater Undifferentiated Carcinoma), [NCIT:C54294](http://purl.obolibrary.org/obo/NCIT_C54294) (Sinonasal Undifferentiated Carcinoma), [NCIT:C9167](http://purl.obolibrary.org/obo/NCIT_C9167) (Undifferentiated Gallbladder Carcinoma), [NCIT:C63622](http://purl.obolibrary.org/obo/NCIT_C63622) (Undifferentiated Carcinoma with Osteoclast-Like Giant Cells), [NCIT:C7100](http://purl.obolibrary.org/obo/NCIT_C7100) (Colon Undifferentiated Carcinoma), [NCIT:C5780](http://purl.obolibrary.org/obo/NCIT_C5780) (Extrahepatic Bile Duct Undifferentiated Carcinoma), [NCIT:C6281](http://purl.obolibrary.org/obo/NCIT_C6281) (Undifferentiated Fallopian Tube Carcinoma), [NCIT:C95965](http://purl.obolibrary.org/obo/NCIT_C95965) (Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells), [NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma), [NCIT:C5947](http://purl.obolibrary.org/obo/NCIT_C5947) (Submandibular Gland Undifferentiated Carcinoma), [NCIT:C7906](http://purl.obolibrary.org/obo/NCIT_C7906) (Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant), [NCIT:C35735](http://purl.obolibrary.org/obo/NCIT_C35735) (Salivary Gland Large Cell Carcinoma), [NCIT:C54339](http://purl.obolibrary.org/obo/NCIT_C54339) (Laryngeal Undifferentiated Carcinoma), [NCIT:C5954](http://purl.obolibrary.org/obo/NCIT_C5954) (Minor Salivary Gland Undifferentiated Carcinoma), [NCIT:C27422](http://purl.obolibrary.org/obo/NCIT_C27422) (Esophageal Undifferentiated Carcinoma), [NCIT:C3878](http://purl.obolibrary.org/obo/NCIT_C3878) (Thyroid Gland Undifferentiated (Anaplastic) Carcinoma), [NCIT:C3779](http://purl.obolibrary.org/obo/NCIT_C3779) (Giant Cell Carcinoma), [NCIT:C7974](http://purl.obolibrary.org/obo/NCIT_C7974) (Rectal Undifferentiated Carcinoma), [NCIT:C43591](http://purl.obolibrary.org/obo/NCIT_C43591) (Colorectal Undifferentiated Carcinoma), [NCIT:C54342](http://purl.obolibrary.org/obo/NCIT_C54342) (Laryngeal Giant Cell Carcinoma), [NCIT:C6345](http://purl.obolibrary.org/obo/NCIT_C6345) (Cervical Undifferentiated Carcinoma), [NCIT:C5476](http://purl.obolibrary.org/obo/NCIT_C5476) (Undifferentiated Gastric Carcinoma), [NCIT:C6168](http://purl.obolibrary.org/obo/NCIT_C6168) (Undifferentiated Urethral Carcinoma), [NCIT:C5597](http://purl.obolibrary.org/obo/NCIT_C5597) (Prostate Undifferentiated Carcinoma), [NCIT:C8024](http://purl.obolibrary.org/obo/NCIT_C8024) (Salivary Gland Undifferentiated Carcinoma), [NCIT:C43556](http://purl.obolibrary.org/obo/NCIT_C43556) (Appendix Undifferentiated Carcinoma), [NCIT:C43538](http://purl.obolibrary.org/obo/NCIT_C43538) (Small Intestinal Undifferentiated Carcinoma), [NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma), [NCIT:C45716](http://purl.obolibrary.org/obo/NCIT_C45716) (NUT Midline Carcinoma), [NCIT:C5838](http://purl.obolibrary.org/obo/NCIT_C5838) (Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type), [NCIT:C96529](http://purl.obolibrary.org/obo/NCIT_C96529) (Anal Canal Undifferentiated Carcinoma), [NCIT:C4509](http://purl.obolibrary.org/obo/NCIT_C4509) (Undifferentiated Ovarian Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation) 66.67%
- [NCIT:C37085](http://purl.obolibrary.org/obo/NCIT_C37085) (Undifferentiated Carcinoma Cell) 66.67%
- [NCIT:C42585](http://purl.obolibrary.org/obo/NCIT_C42585) (Epithelial Differentiation) 52.94%
- Thing 51.13%
- [NCIT:C42095](http://purl.obolibrary.org/obo/NCIT_C42095) (Tissue Differentiation) 46.24%
- [NCIT:C43573](http://purl.obolibrary.org/obo/NCIT_C43573) (Glandular Differentiation) 45.53%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 36.96%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 36.82%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 35.85%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 35.25%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 22.29%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 22.12%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 21.12%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 21.10%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 19.90%


